An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who’s been using semaglutide for weight loss asked online how to switch to “reta” and what dose to start. They’re on 2.16 mg (reported as 76 units on their pen), have lost about 54 pounds, but weight loss has stalled. They want practical advice on what starting dose of reta would be appropriate. Semaglutide is the drug in brand-name products like Ozempic and Wegovy. It mimics a natural hormone from the gut that tells your brain you’re full and slows how fast your stomach empties. People use it with diet and exercise to lose weight or to treat diabetes. “Reta” likely refers to tirzepatide sold as brand names like Mounjaro or Zepbound in some places. Tirzepatide is a newer injectable medication that acts on two gut-hormone receptors at once (it activates both GLP-1 and GIP receptors). In plain terms, it gives stronger signals that reduce appetite and help with blood sugar and weight control. The key thing about the research is that tirzepatide has shown larger average weight loss than semaglutide in clinical trials. But those results come from carefully run studies with specific dosing schedules and medical oversight, not from internet forums. Also, “starting dose” matters: in trials tirzepatide doses were usually ramped up over weeks to reduce side effects like nausea. People switching from semaglutide don’t have a single universal rule for dose switching—doctors typically consider current dose, how you tolerated semaglutide, your weight goals, and other health conditions. The post you shared is one person asking for advice, so it doesn’t provide clinical details or an evidence-based dosing plan. Why this matters is practical: if someone’s weight loss plateaus on semaglutide, tirzepatide may be an option that could produce more weight loss for some people. But switching medicines isn’t just about picking a number on a pen. A healthcare provider can help plan the transition, choose the right initial dose, set up a slow dose escalation to limit side effects, and monitor for blood-sugar or blood-pressure changes and other problems. People with diabetes or taking other medications need extra care during a change like this. Caveats and risks: both drugs can cause nausea, vomiting, diarrhea, constipation, and low blood sugar when used with other diabetes meds. There are rare but serious concerns like pancreatitis (inflammation of the pancreas) and potential thyroid changes in animal studies; long-term safety is still being studied. Over-the-counter or peer-advice dosing from forums is risky. Neither drug should be started, stopped, or dose-changed without medical guidance. Also, availability and approved uses vary by country and by brand, so a doctor can explain what’s legal and safe where you live. Bottom line: tirzepatide may offer stronger weight loss than semaglutide for some people, but dosing and transitions should be handled by a clinician who will tailor the plan to your history, current dose, and side-effect risk.
Source: r/Semaglutide